FDA, flu and vaccine

After canceling meeting of independent advisers, FDA issues 2025-26 flu vaccine recommendations
The US Food and Drug Administration on Thursday issued recommendations for the composition of influenza shots for the upcoming respiratory virus season, but without input from its independent vaccine advisers.
Government panel steps in after FDA cancels advisory meeting on flu shot recommendations
After the FDA canceled a key advisory meeting, government doctors stepped in to propose a trivalent flu vaccine for the upcoming 2025-26 season.
FDA issues flu vaccine recommendations: 5 respiratory updates
Here are four more updates: Influenza activity remained elevated but has been declining for four consecutive weeks. Flu-related emergency department visits remain moderate, and test positivity is at 16.1%.
FDA Makes Flu Vaccine Recommendations Without Convening Advisors
The recommendations were made in a closed session with representatives from CBER, the CDC and Department of Defense.
FDA issues flu vaccine recommendations for 2025-26 season
The Food and Drug Administration has issued recommendations for the composition of influenza shots for the upcoming respiratory virus season, but without input from its independent vaccine advisers.
FDA sets flu shot recommendations without input of outside advisers
The agency formulated its advice to manufacturers after coordinating with the CDC and Defense Department. An advisory meeting that's typically held was canceled last month.
FDA issues flu vaccine recommendations without AdCom input
The U.S. Food and Drug Administration (FDA) has issued its recommendations to vaccine makers on which virus strains to select when manufacturing influenza (flu) vaccines for the 2025-2026 U.S. flu season.
US FDA makes recommendations for influenza vaccines to manufacturers
The U.S. Food and Drug Administration on Thursday made recommendations to vaccine manufacturers for the virus strains to be used in influenza vaccines for the 2025-2026 flu season in the United States.
STAT9h
Altimmune to study obesity drug in alcohol use disorder, following Eli Lilly
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Filter1d
New CDC Leadership Highly Unlikely to End Its Nicotine Misinformation
Trump's nominee to head the CDC has been withdrawn. A shameful record of impeding smoking cessation is likely to continue ...
The Robesonian1h
CDC: Listeria outbreak linked to supplement shakes
CDC, FDA and public health officials in several states are investigating a multistate outbreak of Listeria infections linked to supplement shakes. Many people in this outbreak lived in long-term ...
STAT14h
A ‘conflict of interest-free’ FDA advisory committee policy is a terrible idea
But beware. Health and Human Services Secretary Robert F. Kennedy, Jr. has called for “conflict-free” advisory committee ...
White House withdraws nomination of Dr. Dave Weldon to lead CDC
The White House has withdrawn its nomination of Dr. Dave Weldon to serve as the director of the US Centers for Disease ...
CDC Nomination Hearing Cancelled Minutes Before Start
A Senate committee on Thursday morning cancelled a nomination hearing for Dave Weldon, the former congressman with a history ...
Trump’s NIH and FDA nominees advance to full Senate vote
Two of President Donald Trump’s key public health nominations advanced at the committee level Thursday morning, moving them ...
US FDA's top lawyer Hilary Perkins resigns two days into role
The U.S. Food and Drug Administration's chief counsel, Hilary Perkins, has resigned, the federal agency said in a post on ...